New data suggests that Metformin may help reduce risk for total joint replacement in patients with Type 2 diabetes.
According to findings published in the Canadian Medical Association Journal, the study included 20,347 metformin-treated participants diagnosed with Type 2 diabetes and 20,347 nonusers. Metformin users tended to have more severe diabetes, but only about 16% in both groups had osteoarthritis. However, compared with nonusers, Metformin users had had a 30% lower risk of total knee or hip replacement over a 24-month follow-up period.
To read more, CLICK HERE.